Efficacy and Safety of Dapagliflozin in the Elderly: Analysis From the DECLARE-TIMI 58 Study.
Avivit CahnOfri MosenzonStephen D WiviottAliza RozenbergIlan YanuvErica L GoodrichSabina A MurphyDeepak L BhattLawrence Alan LeiterDarren K McGuireJohn P H WildingIngrid A M Gause-NilssonMartin FredrikssonPeter A JohanssonAnna Maria LangkildeMarc S SabatineItamar RazPublished in: Diabetes care (2019)
The overall efficacy and safety of dapagliflozin are consistent regardless of age.
Keyphrases